New Virginia "Workplace Violence" Definition and Healthcare Reporting Law: What's the Tea in L&E?
Top challenges with Compliance Management
Episode 377 -- Refocusing Due Diligence on Cartels and TCOs
Daily Compliance News: July 11, 2025, The What is a COI Edition
Regulatory Ramblings: Episode 73 - Geopolitical Risk: Thai Tensions / Sanctions, Tariffs & FCPA Enforcement in Asia
Treating Compliance Like an Asset
When DEI Meets the FCA: What Employers Need to Know About the DOJ’s Civil Rights Fraud Initiative
No Password Required: From AOL to Award-Winning Cuisine to High-Stakes Hacking
Compliance Tip of the Day: Lessons from Internal Control Failures
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 241: Fighting Nurse Burnout with Data-Driven Innovation with Dr. Ecoee Rooney of Indicator Sciences
Compliance Tip of the Day: Internal Control Deficiencies
Daily Compliance News: July 8, 2025, The Learning on the Job Edition
#Risk New York Speaker Series – Exploring Future Regulatory Trends and Compliance Strategies with Rory McGrath
FCPA Compliance Report: Stay the Course: Ellen Lafferty on Navigating Anti-Corruption Compliance in 2025
Compliance Tip of the Day: Assessing Internal Controls
Daily Compliance News: July 7, 2025 the Disaster on the River Edition
Multijurisdictional Employers, P2: 2025 State-by-State Updates on Non-Compete/Non-Solicitation Agts
10 For 10: Top Compliance Stories For the Week Ending June 28, 2025
Compliance Tip of the Day: COSO Objective 5 – Monitoring Activities
Episode 30 - Inaugural Episode with Ian Sherr: Compliance Week’s Insights and Reflections from June to July 2025
Risk and compliance leaders face increasing demands to elevate board conversations beyond compliance checkboxes. Boards expect clear insight into how risks affect strategic execution, financial performance, and enterprise...more
How Are Compliance Budgeting and Compliance Officer Autonomy Tied Together When Assessing Compliance Effectiveness? The Department of Justice (“DOJ”)’s compliance program evaluation identifies the need to allocate...more
The drug and medical device industries have been taking it on the FCPA chin for years. The risk factors in the international marketplace are significant – healthcare professionals are normally government employees; government...more